06:52 EDT Rapport Therapeutics (RAPP) files $400M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPP:
- Rapport Therapeutics Elects New Directors at Annual Meeting
- Rapport Therapeutics management to meet with Citizens JMP
- Rapport Therapeutics Completes Enrollment for Phase 2a Trial
- Rapport Therapeutics Reports Q1 2025 Financial Results
- Optimistic Buy Rating for Rapport Therapeutics Driven by Promising RAP-219 Developments